In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1.24% at $463.86. This change lagged the S&P 500's daily ...

Every meal is developed with input from the UFC Performance Institute, the world’s first mixed martial arts multi-disciplinary research, innovation, and performance center. All meals contain 25-60 ...

Vertex Flooring introduces distinctive marquetry flooring crafted with expert precision, offering custom wood designs ...

While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $496.45, a high estimate of $564.00, and a low estimate of $414.00. Witnessing a positive shift, the ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Announcements included the MI440X GPU for on-prem enterprise deployments and a longer-term roadmap that includes rack-scale ...

Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...

Andrew Hill Investment Advisors reports that client portfolios achieved double digit gains during 2025. Review our defensive ...

Summary • UTime Limited (NASDAQ: WTO) rose 14.71% in after-hours trading to $1.17 following a major procurement contract announcement.• The company’s subsidiary secured a nearly $10 million USD deal ...

UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices today announced a major commercial breakthrough. UTime’s Hong Kong subsidiary, UTime ...